
|Videos|July 16, 2018
The Clinical Management of Primary Myelofibrosis
The Clinical Management of Primary Myelofibrosis
Advertisement
March 2017
- A 67-year old woman presents to her primary care physician with complaints of fatigue, abdominal fullness, night sweats, and 17-lb weight loss over the past 6 months.
- PMH includes hypertension, controlled on enalapril 10 mg
- Abdominal examination reveals spleen palpable 7 cm below the costal margin
- Lab values:
- HGB: 9.2 gm/dl
- Platelets: 189 x 109/L
- WBC: 19 x 109/L
- Bone Marrow Biopsy:
- MF-3
- CD34+/CD117+ immunostaining demonstrated 1.2% blasts
- JAK-V617F mutation
- Diagnosis: Primary myelofibrosis
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Oncology Update January 2026: New Horizons in Precision Medicine
2
FDA Accepts BLA for Ivonescimab in Pretreated EGFR-Mutated NSCLC
3
The Targeted Pulse: New Standards in Myeloma, Melanoma, and More
4
Pembrolizumab/Lenvatinib Show Efficacy, Safety in Clear Cell Gyn Cancers
5

















